関連する実験動画
Updated: Aug 3, 2026

09:12
Measuring Deformability and Red Cell Heterogeneity in Blood by Ektacytometry
Published on: January 12, 2018
凝結能力の低下は,アテロゲネシスに臨床的に重要な影響を与えない:遺伝的出血傾向を有する個体における観察
A Srámek1, J H Reiber, W B Gerrits
1Department of Clinical Epidemiology, Leiden University Medical Center, Leiden.
Circulation
|August 15, 2001
まとめ
血友病やフォン・ウィレブランド病などの遺伝性出血疾患を有する個人は,動脈硬化症の発症に対して最小限の保護を示します. 凝固能力の低下は,この心血管疾患の進行に限られた影響を及ぼします.
科学分野:
- 心血管疾患の研究について
- 血液学 ヘマトロジ
- 動脈硬化症の病原病原化について
背景:
- ヘモスタシスは動脈血栓形成において重要な役割を果たし,不全性心血管疾患に影響を及ぼします.
- 新興の証拠は,血液静止は,アテロゲネシスにも影響する可能性があることを示唆しています.
- この研究は,遺伝的な出血傾向が動脈硬化症に対する保護を提供しているかどうかを調査しています.
研究 の 目的:
- 動脈硬化症の発達に対する遺伝性出血傾向の潜在的な保護効果を調査する.
- 健康な対照群と比較して,出血障害のある個体における早期の動脈硬化変化を定量化するために.
主な方法:
- 頸動脈と股関節動脈のインティマ・メディアの厚さを測定するために使用されるBモード超音波検査.
- 研究には,遺伝的に出血傾向 (血友病,ヴォン・ウィレブランド病) を有する76人の個人と,142人の健康な対照群が参加した.
- 測定結果は,動脈硬化症が証明された77人の患者と34人の健康な対照群に対して検証されました.
主要な成果:
- 動脈硬化患者と対照群 (股関節動脈:0.53mm) の間では,インティマ・メディアの厚さの有意な違いが観察されました.
- 血液出血傾向のある個人は,股関節動脈のインティマ・メディアの厚さ (調整された差: -0.078 mm) の最小限の減少のみを示しました.
- 中度から重度の血友病患者は,最も薄い血管壁を示した.
結論:
- 血友病やフォン・ウィルブランド病に関連した低凝固性は,動脈動脈形成に対して限られた保護を提供します.
- 動脈硬化症の進行に対する出血障害の影響は最小限であるように思われる.
関連する概念動画
Mutation, Gene Flow, and Genetic Drift
In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).Mechanisms of Genetic VariationThe original sources of genetic variation are mutations,...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...

